Miri Halperin Wernli - 14 Mar 2023 Form 4/A - Amendment Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role: Executive President, Director
Signature: /s/ Robert Barrow, Attorney-in-Fact
Issuer symbol: MNMD
Transactions as of: 14 Mar 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 24 Apr 2023, 19:33:02 UTC
Date Of Original Report: 17 Mar 2023
Previous filing: 28 Mar 2022
Next filing: 29 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MNMD	Common Shares	Award	$0	+100,000	+118%	$0.000000	185,000	14 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 14, 2023, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date.

Remarks:

Explanatory Note: This Amendment on Form 4/A is being filed to amend the Form 4 filed on March 17, 2023, solely to adjust the number of securities included in Table I under "Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)" to give effect for the 15-for-1 reverse share split the Company effected on August 26, 2022.